Engaging communities to develop and evaluate communication strategies for HIV vaccine and prevention uptake among Black women in the Southern US
This project, in partnership with Baylor College of Medicine, addresses NIMH’s call for HIV vaccine preparedness and “HIV vaccine-related” communication research. Though vaccines may be years away, the time to conduct rigorous HIV vaccine communication research is now – to advance the basic science of effective HIV vaccine messaging and get ahead of misinformation. We will develop and test a multi-component communications intervention to promote uptake of a future HIV vaccine, as part of a comprehensive set of strategies for HIV prevention, among Black women ages 18–34 in the US South. Our diverse team of HIV clinicians, behavioral scientists, and health communication experts includes faculty from Baylor College of Medicine (Awardee), UTHealth Houston School of Public Health, Texas Southern University, and UT Austin Moody School of Communications.
HIV disproportionately impacts young Black women living in the Southern US. Black women make up 13% of the female population in the US, yet make up 54% of new HIV infections among women in the US. These disparities are most extreme in the South, where black women account for 72% of new HIV infections among women. These data highlight the urgent need to develop and scale-up biomedical HIV prevention strategies centered on the unique needs of Black women in the South. This five-year study will take place in Houston, Texas, an epicenter of the HIV epidemic in the US South. We will use community based participatory research methods and Community Engagement Studios to engage young Black women in co-creating and testing communication content across multiple components (i.e., words, graphics, videos). To increase uptake of a future HIV vaccine, we will conduct the following aims: 1) Assess barriers and facilitators to uptake of a future HIV vaccine within the larger family of biomedical HIV prevention tools; 2) Co-create theory-based message features, graphics, and short videos for uptake of a future HIV vaccine. Theory-based features include enhanced active choice, protective agency assignment, autonomy restoration, anticipated affect; and 3) Evaluate the effect of different theory-based message features, graphics and videos on HIV vaccine and prevention intention. We will evaluate effects in three separate randomized trials of young Black women. This proposal takes a rigorous approach to understanding the basic behavioral science of HIV vaccine communication. Communications research is needed to understand how to develop messages that address distinct barriers to seeking out HIV prevention and at the same time, leverage personal and social factors that resonate with Black women. If successful, this model of message design may translate to other long-acting forms of HIV prevention in development.
This project concluded on May 31, 2025.
Project Details
HIV disproportionately impacts young Black women in the Southern US. A future HIV vaccine could decrease disparities, but successful rollout will require communication that is strategic and tailored. We will use Community Engagement Studios to engage young Black women in developing communication strategies and content for uptake of a future HIV vaccine, within the larger family of HIV prevention tools. We will then test these communication strategies in three separate randomized trials to see what types of strategies have the greatest impact on HIV vaccine and prevention intentions.
This project was funded by the National Institutes of Health (1R01MH134749-01A1). Dr. Paula Cuccaro lead the UTHealth Houston team. The study PI at Baylor College of Medicine was Dr. Bich N. Dang. This project concluded on May 31, 2025.
Faculty and Staff
Paula Cuccaro, PhD – Co-Investigator
Christine Markham, PhD – Co-Investigator
Efrat Gabay, MPH – Senior Project Manager
Jihye Choi, PhD – Post-Doctoral Fellow